UK markets closed

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,291.80-12.40 (-0.95%)
At close: 4:38PM GMT
Currency in GBp

Valuation measures

Market cap (intra-day) 564.81B
Enterprise value 395.17B
Trailing P/E 10.23
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1.89
Price/book (mrq)450.26
Enterprise value/revenue 32.78
Enterprise value/EBITDA 69.51

Trading information

Stock price history

Beta (5Y monthly) 0.34
52-week change 3-25.64%
S&P500 52-week change 36.23%
52-week high 31,857.00
52-week low 31,284.00
50-day moving average 31,433.23
200-day moving average 31,567.51

Share statistics

Avg vol (3-month) 37.53M
Avg vol (10-day) 311.56M
Shares outstanding 55.02B
Float 4.92B
% held by insiders 10.93%
% held by institutions 149.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.76
Forward annual dividend yield 45.83%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.06%
5-year average dividend yield 45.22
Payout ratio 463.29%
Dividend date 3N/A
Ex-dividend date 412 Nov 2020
Last split factor 22:1
Last split date 328 Oct 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Sep 2020

Profitability

Profit margin 18.60%
Operating margin (ttm)25.29%

Management effectiveness

Return on assets (ttm)6.60%
Return on equity (ttm)36.53%

Income statement

Revenue (ttm)34.26B
Revenue per share (ttm)6.89
Quarterly revenue growth (yoy)-7.90%
Gross profit (ttm)22.97B
EBITDA 10B
Net income avi to common (ttm)6.37B
Diluted EPS (ttm)126.30
Quarterly earnings growth (yoy)-19.80%

Balance sheet

Total cash (mrq)4.37B
Total cash per share (mrq)0.88
Total debt (mrq)28.25B
Total debt/equity (mrq)136.96
Current ratio (mrq)0.90
Book value per share (mrq)2.87

Cash flow statement

Operating cash flow (ttm)8.04B
Levered free cash flow (ttm)4.71B